News and features

Articles

Showing 131 - 140 of 194

News & Analysis

KWM and Clifford Chance act on China Baowu’s acquisition of Magang

02 January 2020 by Asia law

The deal gives Baowu a 51 percent stake in Magang
News & Analysis

Kewei expands joint operation expertise in Shanghai

20 December 2019 by Asia law

Firm expands through its joint operation with Herbert Smith Freehills
News & Analysis

Haiwen and KWM act on PSBC’s $4.67 billion IPO in Shanghai

17 December 2019 by Asia law

This is the largest IPO in mainland China in four years
News & Analysis

Perkins Coie strengthens China practice

17 December 2019 by Asia law

Firm opens new IP agency, new Shenzhen location, and expands Beijing office
News & Analysis

JunHe recruits new bankruptcy partner in Shenzhen

11 December 2019 by Asia law

The firm hires bankruptcy expert in its Shenzhen office from Zhong Lun
News & Analysis

JunHe and Commerce & Finance Law Offices advise Kingsoft Office on its $655 million IPO

10 December 2019 by Asia law

This is the largest IPO on Shanghai’s Star Market till date
News & Analysis

Fangda and Simpson Thacher advise on Alibaba’s $11.3 billion secondary listing

09 December 2019 by Asia law

The first Chinese Internet company to be listed on both the US and HKSAR
News & Analysis

KWM strengthens Greater Bay Area practice with new hires

04 December 2019 by Asia law

Firm recruits PPP, cap markets, real estate experts in GBA and South-East China
News & Analysis

KWM advises on New Hope’s RMB710 million acquisition of China Modern Dairy Holdings

05 November 2019 by Asia law

King & Wood Mallesons acted as the legal counsel of New Hope Dairy
News & Analysis

JunHe receives ‘Tier One’ rankings across all seven practice areas and 21 JunHe lawyers are named in the IFLR1000 for 2020

23 October 2019 by Asia law

Recently, the International Financial Law Review (IFLR1000) published the IFLR1000 2020 firm rankings and lawyer ratings. JunHe received ‘Tier One’ rankings in all seven practice areas and 21 JunHe lawyers were named in the IFLR1000 2020.
Load more